NCT00771160View on ClinicalTrials.gov

MK0476 Study in Adult Patients With Perennial Allergic Rhinitis (0476-397)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Rhinitis, Allergic
Interventions
DRUG

montelukast sodium

Arm 1: montelukast tablet 5 mg, QD. Treatment period is 12-weeks. Arm 2: montelukast tablet 10 mg, QD. Treatment period is 12-weeks.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00771160 - MK0476 Study in Adult Patients With Perennial Allergic Rhinitis (0476-397)(COMPLETED) | Biotech Hunter | Biotech Hunter